LRRK2 and B-cell chronic lymphocytic leukemia: As illustrated in Fig 6, Mut3DPT-LRRK2-Short looks slightly higher fluorescence intensity than Mut3DPT-LRRK2-Long for both, healthy donors and CLL patients.